Literature DB >> 28818638

Association of hemoglobin A1c variability and the incidence of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and arterial hypertension.

Jun Gu1, Yu-Qi Fan2, Jun-Feng Zhang2, Chang-Qian Wang3.   

Abstract

BACKGROUND: This study aimed to investigate the association between variability in hemoglobin A1c (HbA1c) and left ventricular (LV) diastolic function and incidence of symptomatic heart failure with preserved ejection fraction (HFpEF) in patients with type 2 diabetes mellitus (T2DM) and arterial hypertension.
METHODS: A retrospective cohort study was conducted on eligible patients with T2DM and hypertension and without clinical signs or symptoms of heart failure in our hospital medical record database. Variability in HbA1c was measured by standard deviation (SD) and coefficient of variation (CV). Risk of new onset of symptomatic HFpEF was evaluated by multivariable cox regression analysis.
RESULTS: A total of 201 subjects were categorized according to the median value of HbA1c variability indicators. Over a median follow-up of 7.3 years, the percentage of subjects who had new incidence of symptomatic HFpEF was higher in those with higher HbA1c-SD level (5/105 vs. 13/96, P=0.029) and higher HbA1c-CV level (5/101 vs. 13/100, P=0.046). Multivariable cox regression analysis also showed that higher HbA1c variability [HbA1c-SD (HR 1.754, 95% CI: 1.003-3.104, P=0.049) or HbA1c-CV (HR 1.604 95% CI: 1.064-2.419, P=0.024)] was associated with the presence of new-onset symptomatic HFpEF, independent of HbA1c-mean level, in T2DM and hypertensive patients. Moreover, lower HbA1c variability generated more prominent improvement in LV diastolic function (E/E') during the follow-up.
CONCLUSIONS: HbA1c variability may provide additional valuable information as a potential predictor of the progression of HFpEF in T2DM and hypertensive patients.
Copyright © 2018 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  diastolic function; heart failure with preserved ejection fraction; hemoglobin A1c variability; hypertension; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2017        PMID: 28818638     DOI: 10.1016/j.hjc.2017.08.001

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  8 in total

1.  Prognostic impact of visit-to-visit glycemic variability on the risks of major adverse cardiovascular outcomes and hypoglycemia in patients with different glycemic control and type 2 diabetes.

Authors:  Bao Sun; Fazhong He; Yongchao Gao; Jiecan Zhou; Lei Sun; Rong Liu; Heng Xu; Xiaoping Chen; Honghao Zhou; Zhaoqian Liu; Wei Zhang
Journal:  Endocrine       Date:  2019-03-13       Impact factor: 3.633

2.  Glucose variability predicts 6-month mortality in patients hospitalized with acute heart failure.

Authors:  Filipe M Cunha; Catarina Cidade-Rodrigues; Catarina Elias; Diana Oliveira; Paulo Bettencourt; Patrícia Lourenço
Journal:  Intern Emerg Med       Date:  2021-04-05       Impact factor: 3.397

3.  Diabetes mellitus: Lessons from the COVID-19 pandemic.

Authors:  Dimitris Tousoulis
Journal:  Hellenic J Cardiol       Date:  2020-05-18

Review 4.  Glycemic variability: adverse clinical outcomes and how to improve it?

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Chunsheng Zhu; Meng Bian
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

5.  Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study.

Authors:  You-Bin Lee; Kyungdo Han; Bongsung Kim; Seung-Eun Lee; Ji Eun Jun; Jiyeon Ahn; Gyuri Kim; Sang-Man Jin; Jae Hyeon Kim
Journal:  Cardiovasc Diabetol       Date:  2019-11-16       Impact factor: 9.951

Review 6.  Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications.

Authors:  Bao Sun; Zhiying Luo; Jiecan Zhou
Journal:  Cardiovasc Diabetol       Date:  2021-01-07       Impact factor: 9.951

7.  Intermediate- and long-term associations between air pollution and ambient temperature and glycated hemoglobin levels in women of child bearing age.

Authors:  Mike Z He; Itai Kloog; Allan C Just; Iván Gutiérrez-Avila; Elena Colicino; Martha M Téllez-Rojo; María Luisa Pizano-Zárate; Marcela Tamayo-Ortiz; Alejandra Cantoral; Diana C Soria-Contreras; Andrea A Baccarelli; Robert O Wright; Maayan Yitshak-Sade
Journal:  Environ Int       Date:  2022-05-14       Impact factor: 13.352

8.  Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.

Authors:  Jun Gu; Jian-An Pan; Yu-Qi Fan; Hui-Li Zhang; Jun-Feng Zhang; Chang-Qian Wang
Journal:  Cardiovasc Diabetol       Date:  2018-06-30       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.